The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
暂无分享,去创建一个
S. Montoto | N. Kröger | I. Yakoub-Agha | M. Mohty | J. Snowden | H. Baldomero | J. Passweg | C. Chabannon | G. Basak | A. Lankester | J. Styczyński | S. Corbacioglu | J. Kuball | M. Arat | R. Duarte | R. D. de Latour